The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Vasograin Plus represents a major advancement in the treatment of migraine
A triple-action Formula for comprehensive respiratory relief
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
Subscribe To Our Newsletter & Stay Updated
